Patent ID: 7214716
Filing Date: 2007-05-08
Classification: A61K,A61P

Abstract:
1. A method of treating a disease or disorder that is mediated by peripheral cannabinoid receptors CB2 in an animal, which comprises administering to an animal in need of such treatment a pharmaceutical composition that includes a therapeutically effective amount of a C2 agonist that binds to such receptors to treat the disease or disorder, wherein the CB2 agonist is a compound of the general formula: having the (3S,4S) configuration, and which is essentially free of the (3R,4R) enantiomer, wherein: A—B designates an optional double bond, R G is hydrogen, halogen, or —OR R wherein the disease or disorder to be treated is hypertension, gastrointestinal disorders, tumors expressing CB2 receptors or autoimmune diseases and the pharmaceutical composition is administered to an individual in a therapeutically effective amount for treating the disease or disorder.